EA201490041A1 - Пластырь, содержащий диклофенак и тиоколхикозид - Google Patents

Пластырь, содержащий диклофенак и тиоколхикозид

Info

Publication number
EA201490041A1
EA201490041A1 EA201490041A EA201490041A EA201490041A1 EA 201490041 A1 EA201490041 A1 EA 201490041A1 EA 201490041 A EA201490041 A EA 201490041A EA 201490041 A EA201490041 A EA 201490041A EA 201490041 A1 EA201490041 A1 EA 201490041A1
Authority
EA
Eurasian Patent Office
Prior art keywords
thyokolchicosid
containing diclofenac
plaster containing
diclofenac
plaster
Prior art date
Application number
EA201490041A
Other languages
English (en)
Other versions
EA025793B1 (ru
Inventor
Джузеппе Ирьянни
Original Assignee
Эпифарма Срл
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эпифарма Срл filed Critical Эпифарма Срл
Publication of EA201490041A1 publication Critical patent/EA201490041A1/ru
Publication of EA025793B1 publication Critical patent/EA025793B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Настоящее изобретение относится к пластырю для чрескожной доставки диклофенака или его фармацевтически приемлемой соли, в частности соли с диэтиламином, и тиоколхикозида.
EA201490041A 2011-07-20 2012-06-15 Пластырь, содержащий диклофенак и тиоколхикозид EA025793B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001355A ITMI20111355A1 (it) 2011-07-20 2011-07-20 Cerotto transdermico contenente diclofenac e tiocolchicoside
PCT/EP2012/061468 WO2013010737A1 (en) 2011-07-20 2012-06-15 Patch containing diclofenac and thiocolchicoside

Publications (2)

Publication Number Publication Date
EA201490041A1 true EA201490041A1 (ru) 2014-05-30
EA025793B1 EA025793B1 (ru) 2017-01-30

Family

ID=44545826

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201490041A EA025793B1 (ru) 2011-07-20 2012-06-15 Пластырь, содержащий диклофенак и тиоколхикозид

Country Status (14)

Country Link
US (1) US9220690B2 (ru)
EP (1) EP2734196B1 (ru)
JP (1) JP2014520867A (ru)
CN (1) CN103702667A (ru)
AU (1) AU2012286133A1 (ru)
BR (1) BR112014001096A2 (ru)
CA (1) CA2842273A1 (ru)
EA (1) EA025793B1 (ru)
ES (1) ES2660019T3 (ru)
IL (1) IL230482A0 (ru)
IT (1) ITMI20111355A1 (ru)
MX (1) MX2014000751A (ru)
WO (1) WO2013010737A1 (ru)
ZA (1) ZA201400394B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104415024B (zh) * 2013-08-22 2018-05-11 和心医药科技（上海）有限公司 含双氯芬酸的巴布剂、及其组合物和制备方法
US9962349B2 (en) 2014-10-17 2018-05-08 Fidia Farmaceutici S.P.A. Dermal therapeutic system with high adhesivity
US11123414B2 (en) * 2017-12-22 2021-09-21 Produits Naturasense Inc. Non-carcinogenic cream for delivery of active ingredient into the dermis
USD980359S1 (en) 2021-01-20 2023-03-07 Karsten Manufacturing Corporation Golf club head
USD972674S1 (en) 2021-01-20 2022-12-13 Karsten Manufacturing Corporation Golf club head

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61280426A (ja) 1985-06-04 1986-12-11 Ikeda Mohandou:Kk 消炎鎮痛用貼付剤
CH666621A5 (de) 1986-06-27 1988-08-15 Ciba Geigy Ag Topisch applizierbare pharmazeutische zusammensetzungen mit systemischer wirkung.
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
JPH0656660B2 (ja) 1990-05-18 1994-07-27 三洋電機株式会社 駆動電圧発生回路
JPH04261119A (ja) 1991-02-13 1992-09-17 Lintec Corp 経皮吸収型貼付剤
JP3086290B2 (ja) 1991-07-26 2000-09-11 エスエス製薬株式会社 ジクロフェナクナトリウム貼付剤
FR2735369B1 (fr) * 1995-06-13 1997-07-11 Synthelabo Compositions pharmaceutiques a base de sel de sodium du diclofenac et de thiocolchicoside
DE19653605C2 (de) * 1996-12-20 2002-11-28 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems
JP4181232B2 (ja) 1997-07-18 2008-11-12 帝國製薬株式会社 ジクロフェナクナトリウム含有油性外用貼付製剤
US6193996B1 (en) 1998-04-02 2001-02-27 3M Innovative Properties Company Device for the transdermal delivery of diclofenac
JP4275768B2 (ja) * 1998-06-18 2009-06-10 久光製薬株式会社 水性粘着膏体
ITMI20012827A1 (it) * 2001-12-28 2003-06-28 Fidia Farmaceutici Formulazioni adesive transdermiche di diclofenac sodico
JP4764337B2 (ja) * 2004-04-23 2011-08-31 久光製薬株式会社 消炎鎮痛貼付剤
ITMI20041492A1 (it) * 2004-07-23 2004-10-23 Italiano Biochimico Far Maceut Nuovo dispositivo per il rilascio di principi attivi
DK1877509T3 (da) * 2005-03-17 2012-01-23 Pharmafilm S R L Vandigt polymersystem til trykfølsom klæbemiddelmatrixfremstilling
WO2008109018A1 (en) * 2007-03-02 2008-09-12 Meda Pharmaceuticals Inc. Compositions comprising carisoprodol and methods of use thereof
IT1392180B1 (it) * 2008-12-11 2012-02-22 Bouty Spa Un sistema matriciale auto-adesivo comprendente un copolimero a blocchi stirenico
US20110244023A1 (en) * 2010-03-30 2011-10-06 Phosphagenics Limited Transdermal delivery patch

Also Published As

Publication number Publication date
AU2012286133A1 (en) 2014-02-06
WO2013010737A1 (en) 2013-01-24
ITMI20111355A1 (it) 2013-01-21
MX2014000751A (es) 2014-10-15
US9220690B2 (en) 2015-12-29
US20140155342A1 (en) 2014-06-05
ES2660019T3 (es) 2018-03-20
BR112014001096A2 (pt) 2018-10-30
JP2014520867A (ja) 2014-08-25
ZA201400394B (en) 2015-05-27
IL230482A0 (en) 2014-03-31
EA025793B1 (ru) 2017-01-30
CA2842273A1 (en) 2013-01-24
EP2734196A1 (en) 2014-05-28
EP2734196B1 (en) 2017-12-06
CN103702667A (zh) 2014-04-02

Similar Documents

Publication Publication Date Title
EA201390804A1 (ru) Лекарственная форма лакозамида для приема один раз в сутки
CY1119798T1 (el) Μορφη iv υδροχλωρικης ιβαμπραδινης
EA201790785A1 (ru) Производные тетрагидроизохинолина
EA201490559A1 (ru) Композиция для лечения свища
BR112015004936A2 (pt) composição farmacêutica revestida contendo regorafenib
MX349224B (es) Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa.
BR112014006419A2 (pt) métodos para tratar um paciente com câncer, kit e artigo
EA201492287A1 (ru) Дейтерированные производные руксолитиниба
EA201400771A1 (ru) Новые производные азетидина, фармацевтические композиции и их применение
MY168300A (en) Pharmaceutical Composition for Inhalation
MX356728B (es) Combinación farmacéutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2.
BR112014025041B8 (pt) Composição farmacêutica
MX344473B (es) Composicion farmaceutica acuosa semisolida que contiene tapentadol.
EA201490761A1 (ru) R(+)-n-формилпропаргиламиноиндан
CO6920289A2 (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib.
BR112014002845A2 (pt) “composto, sal farmaceuticamente aceitável, composição farmacêutica, e, uso de um composto”
CL2014001861A1 (es) Compuestos derivados de bencil sulfonamida, inhibidores de mogat-2; compuesto cristalino; composicion farmaceutica; y su uso en el tratamiento de la hipertrigliceridemia.
CO6741197A2 (es) Proteína de fusión robo1-fc para uso en el tratamiento del hepatocarcinoma
EA201490041A1 (ru) Пластырь, содержащий диклофенак и тиоколхикозид
HK1190646A1 (zh) 外用劑試劑盒
BR112014001425A2 (pt) forma de dosagem farmacêutica, composição farmacêutica, e, composto (i) ou sal farmaceuticamente aceitável do mesmo
EA201491300A1 (ru) Композиция для назального применения с улучшенной стабильностью
BR112014009760A2 (pt) análogos de ácido siálico, seu uso e composição farmacêutica e composição farmacêutica de liberação sustentada os compreendendo
EA201391643A1 (ru) Составы с замедленным высвобождением парацетамола
AR098614A1 (es) Compuesto para el tratamiento de hipoglicemia severa

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM BY KG TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AZ KZ RU